Oncology
Research activity is centered on small cell lung cancer, with interest in treatments for an aggressive thoracic malignancy that requires targeted therapeutic development.
- Small cell lung cancer
- Thoracic oncology
- Cancer therapeutics
The sponsor’s clinical work in this area reflects a focus on advancing medical options for patients with limited treatment choices in lung cancer.
Anticancer Drug Development
Its research portfolio includes the evaluation of novel antineoplastic agents designed for solid tumor treatment, with emphasis on identifying clinically relevant activity in oncology.
- Novel anticancer agents
- Solid tumor therapy
- Targeted cancer treatment
This area supports the development of new treatment approaches for malignancies with high unmet medical need.
Clinical Pharmacology
Research interest extends to pharmacokinetics and drug tolerability, including how investigational therapies are handled by the body in patients with cancer.
- Pharmacokinetics
- Drug tolerability
- Absorption, distribution, metabolism, and excretion
These studies support understanding of treatment behavior in the clinical oncology setting.
Translational Cancer Research
The sponsor is involved in research that links laboratory-based therapeutic concepts with patient-focused evaluation in cancer medicine, particularly for advanced lung malignancies.
- Translational oncology
- Advanced malignancies
- Patient-centered cancer evaluation
Its funded work contributes to the clinical assessment of emerging therapies for small cell lung cancer.
